ESMO Handbook: Cancer Treatment in Special Clinical Situations - Editors and Contributors

Editors

Veronika Ballová

Národný Onkologický Ústav, Bratislava, Slovak Republic

Mariano Provencio Pulla

Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain

Contributors

Chapter 1: Cancer Treatment during Pregnancy

Azim H.A. Jr. Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium

Peccatori F.A. Division of Gynecologic Oncology, Fertility and Procreation Unit, European Institute of Oncology, Milan, Italy

Chapter 2: Cancer Treatment in Patients with Renal Insufficiency

Peyrade F. Department of Hemato-oncology, Centre Régional de Lutte Contre le Cancer, Nice, France

Thyss A. Department of Hemato-oncology, Centre Régional de Lutte Contre le Cancer, Nice, France

Chapter 3: Cancer Treatment in Patients with Hepatic Dysfunction

Joerger M. Department of Medical Oncology & Hematology, Cantonal Hospital, St. Gallen, Switzerland

Beumer J.H. University of Pittsburgh Cancer Institute and Department of Pharmaceutical Sciences, University of Pittsburgh, Pennsylvania, USA

Chapter 4: Cancer Treatment in Solid Organ Transplant Recipients

Venugopal B. Beatson West of Scotland Cancer Centre, Glasgow, UK

Wilson C. Beatson West of Scotland Cancer Centre, Glasgow, UK

Parker A. Beatson West of Scotland Cancer Centre, Glasgow, UK

Chapter 5: Cancer Treatment in Patients with HIV

Spina M. Division of Medical Oncology A, National Cancer Institute, Aviano (PN), Italy

Bearz A. Division of Medical Oncology A, National Cancer Institute, Aviano (PN), Italy

Berretta M. Division of Medical Oncology A, National Cancer Institute, Aviano (PN), Italy

Vaccher E. Division of Medical Oncology A, National Cancer Institute, Aviano (PN), Italy

Tirelli U. Division of Medical Oncology A, National Cancer Institute, Aviano (PN), Italy

Chapter 6: Cancer Treatment in Patients with Hepatitis

de la Revilla J. Gastroenterology and Hepatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain

Calleja J.L. Gastroenterology and Hepatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain

Abreu L. Gastroenterology and Hepatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain

Chapter 7: Cancer Treatment in Patients with Diabetes

Mateo J. The Royal Marsden NHS Foundation Trust, Sutton, UK

Castro E. Spanish National Cancer Research Centre, Madrid, Spain

Olmos D. Spanish National Cancer Research Centre, Madrid, Spain

Chapter 8: Cancer Treatment in Patients with Heart Disease

Curigliano G. Department of Medicine, Division of Early Drug Development, European Institute of Oncology, Milan, Italy

Mandala M. Unit of Clinical and Translational Research, Department of Oncology and Haematology, Division of Medical Oncology, Papa Giovanni XXIII Hospital, Bergamo, Italy

Cipolla C.M. Division of Cardiology, European Institute of Oncology, Milan, Italy

Chapter 9: Cancer Treatment in Patients with Religious Constraints

Plana J. Borja Institute of Bioethics, Ramon Llull University, Barcelona, Spain

Terribas N. Borja Institute of Bioethics, Ramon Llull University, Barcelona, Spain

Chapter 10: Cancer Treatment in Patients Unable to Consent

Jovell A.J. Universitat Internacional de Catalunya, Sant Cugat del Vallés, Spain

Navarro M.D. Universitat Internacional de Catalunya, Sant Cugat del Vallés, Spain

Declaration of Interest:

Chapter 1: Dr Azim Jr and Dr Peccatori have reported no conflicts of interest.

Chapter 2: Dr Peyrade has reported that he is on the board of Merck. Dr Thyss has reported no conflicts of interest.

Chapter 3: Dr Joerger has reported no conflicts of interest. Dr Beumer reported that he receives research funding from Spectrum, BMS and Novartis, and that his wife is an employee of GlaxoSmithKline.

Chapter 4: Dr Venugopal, Dr Wilson and Dr Parker have reported no conflicts of interest.

Chapter 5: Dr Spina, Dr Bearz, Dr Berretta, Dr Vaccher, and Dr Tirelli have reported no conflicts of interest.

Chapter 6: Dr de la Revilla, Dr Calleja, and Dr Abreu have reported no conflicts of interest.

Chapter 7: Dr Mateo, Dr Castro, and Dr Olmos have reported no conflicts of interest.

Chapter 8: Dr Curigliano, Professor Mandala, and Dr Cipolla have reported no conflicts of interest.

Chapter 9: Dr Plana, and Dr Terribas have reported no conflicts of interest.

Chapter 10: Dr Jovell has an academic position and is not involved in the prescription of any medical tests or therapies, nor sits on any committees involved in the regulation of drugs or procedures. Dr Navarro has an academic position and is not involved in the prescription of any medical tests or therapies, nor sits on any committees involved in the regulation of drugs or procedures.

« Previous Page Next Page »

Last update: 01 October 2013